Elexacaftor-tezacaftor-ivacaftor increases airway nitric oxide in children with cystic fibrosis
Journal of Cystic Fibrosis · 2024
DOI: 10.1016/j.jcf.2023.05.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2024. Verfasst von Isaac Martin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respiratory Medicine, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, M5G 1 × 8, Canada; D…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Indoles, Pyrazoles, Pyridines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Cystic Fibrosis Canada.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Respiratory Medicine, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, M5G 1 × 8, Canada; Department of Paediatrics and Translational Medicine, Research Institut…
- Division of Respiratory Medicine, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, M5G 1 × 8, Canada.
Förderung
- Cystic Fibrosis Canada
Zitieren
APA
Martin, I., McDonald, N., Wilson, D., Ratjen, F., & Grasemann, H. (2024). Elexacaftor-tezacaftor-ivacaftor increases airway nitric oxide in children with cystic fibrosis. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2023.05.015
Vancouver
Martin I, McDonald N, Wilson D, Ratjen F, Grasemann H. Elexacaftor-tezacaftor-ivacaftor increases airway nitric oxide in children with cystic fibrosis. Journal of Cystic Fibrosis. 2024. doi:10.1016/j.jcf.2023.05.015
BibTeX
@article{Martin2024,
author = {Martin, Isaac and McDonald, Nancy and Wilson, David and Ratjen, Felix and Grasemann, Hartmut},
title = {Elexacaftor-tezacaftor-ivacaftor increases airway nitric oxide in children with cystic fibrosis},
journal = {Journal of Cystic Fibrosis},
year = {2024},
doi = {10.1016/j.jcf.2023.05.015}
}
EUVIMED